Literature DB >> 8815694

Current clinical experience with nevirapine for HIV infection.

A Carr1, D A Cooper.   

Abstract

Nevirapine is a potent antiretroviral agent whose use, especially as monotherapy, may be limited by rapid onset of resistance as well as by hypersensitivity reactions. However, virologic features of nevirapine suggest that it may be useful in combination therapy with zidovudine or other antiretrovirals, including for patients infected with zidovudine-resistant strains HIV.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8815694     DOI: 10.1007/978-1-4757-9209-6_27

Source DB:  PubMed          Journal:  Adv Exp Med Biol        ISSN: 0065-2598            Impact factor:   2.622


  5 in total

1.  SJ-3366, a unique and highly potent nonnucleoside reverse transcriptase inhibitor of human immunodeficiency virus type 1 (HIV-1) that also inhibits HIV-2.

Authors:  R W Buckheit; K Watson; V Fliakas-Boltz; J Russell; T L Loftus; M C Osterling; J A Turpin; L A Pallansch; E L White; J W Lee; S H Lee; J W Oh; H S Kwon; S G Chung; E H Cho
Journal:  Antimicrob Agents Chemother       Date:  2001-02       Impact factor: 5.191

2.  Unique anti-human immunodeficiency virus activities of the nonnucleoside reverse transcriptase inhibitors calanolide A, costatolide, and dihydrocostatolide.

Authors:  R W Buckheit; E L White; V Fliakas-Boltz; J Russell; T L Stup; T L Kinjerski; M C Osterling; A Weigand; J P Bader
Journal:  Antimicrob Agents Chemother       Date:  1999-08       Impact factor: 5.191

3.  Investigating time dependent brain distribution of nevirapine via mass spectrometric imaging.

Authors:  Sipho Mdanda; Sphamandla Ntshangase; Sanil D Singh; Tricia Naicker; Hendrik G Kruger; Sooraj Baijnath; Thavendran Govender
Journal:  J Mol Histol       Date:  2019-11-04       Impact factor: 2.611

4.  Nevirapine induced Stevens-Johnson syndrome in an HIV infected patient.

Authors:  Harminder Singh; Vinay Kumar Kachhap; Bithika Nel Kumar; Kalpana Nayak
Journal:  Indian J Pharmacol       Date:  2011-02       Impact factor: 1.200

5.  Nevirapine induced toxic epidermal necrolysis and non-Hodgkin lymphoma in a Human Immunodeficiency Virus positive patient.

Authors:  Leelavathy Budamakuntla; Eswari Loganathan; Shwetha Suryanarayan; Kumar Abhishek; Sacchidanand Sarvajnamurthy
Journal:  Indian Dermatol Online J       Date:  2014-04
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.